1. Home
  2. Browse
  3. National Institutes of Health

384 open · review criteria on file for 58

National Institutes of Health

384 open opportunities; review criteria are on file for 58 of them. Sorted by deadline, soonest first.

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

PAR-25-226National Institutes of Health3 review criteria on fileagency framework

—

Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)

RFA-DE-27-001National Institutes of Health3 review criteria on file

—

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

RFA-CA-27-019National Institutes of Health4 review criteria on file

$300k

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-020National Institutes of Health8 review criteria on file

$600k

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

PAR-25-296National Institutes of Health5 review criteria on file

$650k

PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)

RFA-RM-27-012National Institutes of Health3 review criteria on file

—

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

PAR-25-155National Institutes of Health3 review criteria on file

$50k

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-021National Institutes of Health8 review criteria on fileagency framework

$600k

Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)

RFA-RM-27-013National Institutes of Health3 review criteria on file

—

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

PAR-25-052National Institutes of Health3 review criteria on fileagency framework

—

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

PAR-25-120National Institutes of Health3 review criteria on fileagency framework

—

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

PAR-25-343National Institutes of Health4 review criteria on file

—

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158National Institutes of Health3 review criteria on fileagency framework

—

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

PAR-25-225National Institutes of Health3 review criteria on file

—

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

PAR-25-268National Institutes of Health3 review criteria on file

—

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

PAR-25-270National Institutes of Health3 review criteria on file

$1.1M

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

PAR-25-446National Institutes of Health3 review criteria on fileagency framework

$3M

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

PAR-25-274National Institutes of Health3 review criteria on file

—

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

PAR-25-267National Institutes of Health3 review criteria on file

$350k

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

PAR-25-371National Institutes of Health3 review criteria on fileagency framework

—

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

PAR-25-369National Institutes of Health3 review criteria on fileagency framework

—

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

PAR-25-271National Institutes of Health3 review criteria on file

—

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)

RFA-DK-27-120National Institutes of Health13 review criteria on file

$750k

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

PAR-25-059National Institutes of Health3 review criteria on file

$750k

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

PAR-25-269National Institutes of Health3 review criteria on file

$350k

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

PAR-25-060National Institutes of Health3 review criteria on file

$750k

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

PAR-25-024National Institutes of Health3 review criteria on file

—

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)

RFA-HD-27-007National Institutes of Health3 review criteria on fileagency framework

$200k

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

RFA-HL-26-016National Institutes of Health3 review criteria on file

$350k

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

PAR-25-379National Institutes of Health3 review criteria on file

—

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

RFA-HL-26-018National Institutes of Health4 review criteria on file

—

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

RFA-HL-26-020National Institutes of Health4 review criteria on file

—

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-27-007National Institutes of Health3 review criteria on file

—

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

RFA-HL-26-017National Institutes of Health4 review criteria on file

—

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

PAR-25-378National Institutes of Health3 review criteria on file

—

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

RFA-HL-26-019National Institutes of Health4 review criteria on file

—

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)

RFA-MH-27-140National Institutes of Health3 review criteria on file

—

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)

PAR-25-134National Institutes of Health3 review criteria on fileagency framework

$375k

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

PAR-25-104National Institutes of Health4 review criteria on file

—

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

PAR-25-353National Institutes of Health7 review criteria on file

—

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

PAR-25-298National Institutes of Health3 review criteria on fileagency framework

$375k

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

PAR-27-078National Institutes of Health3 review criteria on fileagency framework

$375k

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

PAR-24-214National Institutes of Health6 review criteria on fileagency framework

$375k

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

PAR-25-352National Institutes of Health3 review criteria on file

—

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

PAR-25-148National Institutes of Health3 review criteria on fileagency framework

—

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

PAR-25-322National Institutes of Health3 review criteria on file

—

HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)

RFA-AT-25-003National Institutes of Health3 review criteria on file

$375k

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

PAR-27-045National Institutes of Health

—

GREGoRi Innovation Projects (U01 Clinical Trial Optional)

RFA-HG-27-013National Institutes of Health3 review criteria on fileagency framework

$500k

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

PAR-24-027National Institutes of Health

—

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

RFA-HG-27-012National Institutes of Health3 review criteria on file

$2.3M

GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

RFA-HG-27-011National Institutes of Health3 review criteria on file

$1.3M

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

PAR-27-011National Institutes of Health3 review criteria on file

—

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-141National Institutes of Health5 review criteria on file

—

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

PAR-24-280National Institutes of Health3 review criteria on fileagency framework

—

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

PAR-24-279National Institutes of Health3 review criteria on fileagency framework

—

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

PAR-27-013National Institutes of Health8 review criteria on file

—

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

PAR-27-012National Institutes of Health3 review criteria on file

—

Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)

PAR-25-437National Institutes of Health7 review criteria on file

—

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

PAR-25-338National Institutes of Health3 review criteria on file

$499k

Showing the 60 soonest of 384. Search the rest by title or code on Browse, no account needed.

Read the review criteria before you apply

A free account shows the review criteria on file and the announcement text where we hold it. The eligibility check, funded precedents and the Reviewer Scorecard are on Plus, $39 a month. No card required.

Create free accountBrowse all funders

Other funders